Clinical Trials in Tennessee

Showing 18381-18400 of 20,239 trials

Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401

NCT01105117

This is an open-label, non-randomized extension to study AC-066A401. The study will assess safety and tolerability of ACT-385781A and Flolan (epoprostenol sodium) while providing a means for continuing treatment after ending participation in study AC-0066A401.

Pulmonary Arterial Hypertension

Actelion2 participantsStarted May 2010

La Jolla, California, United States • Aurora, Colorado, United States • Durham, North Carolina, United States +4 more locations

COMPLETEDPhase 229 miles

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

NCT00293657

To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for the acute treatment of moderate or severe headache associated with a single migraine attack in patients with a history of migraine. Two-thirds of patients in this study will receive a single dose of intravenous lornoxicam (8mg or 16 mg) and one-third of patients will receive a single dose of an intravenous placebo.

Headache (Migraine)

POZEN150 participantsStarted Dec 2005

Birmingham, Alabama, United States • Mobile, Alabama, United States • Little Rock, Arkansas, United States +20 more locations

Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

Find Trials by Condition in Tennessee

A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)

Screening for Early Evidence of Diabetes

Fibromyalgia Health Outcome Study on Cost of Treatments

Evaluation of Low Source of Signal in SCOUT DS

Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal Failure

Study to Evaluate the Safety and Efficacy of the Renal Assist Device in Patients With Acute Renal Failure

Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

Xpress Digital Mammography System Images for Computer Aided Detection Development

Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

Validation of PROMIS Banks With COPD Exacerbations

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission

6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)